S1P 1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity

Journal of Lipid Research

Volumn 54, Issue 3, 2013, Pages 843-851

  Montrose, David C ^a   Scherl, Ellen J ^a   Bosworth, Brian P ^a   Zhou, Xi Kathy ^a   Jung, Bongnam ^a   Dannenberg, Andrew J ^a   Hla, Timothy ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Endothelial cells; Fingolimod; Gastrointestinal bleeding; Infl ammatory bowel disease; Sphingosine 1 phosphate

Indexed keywords

3 [2 (3 TRIFLUOROMETHYL 4 BIPHENYLYL)BENZO[B]THIEN 5 YLMETHYLAMINO]PROPIONIC ACID; DEXTRAN SULFATE; FINGOLIMOD; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD VESSEL PERMEABILITY; COLON BLOOD FLOW; COLON MUCOSA; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

ANIMALS; BETA-ALANINE; CAPILLARY PERMEABILITY; COLITIS, ULCERATIVE; COLON; HUMANS; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; PROPYLENE GLYCOLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; THIOPHENES;

EID: 84874064551     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M034108     Document Type: Article

References (41)

1. Blaho, V. A., and T. Hla. 2011. Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. Chem. Rev. 111 : 6299-6320.
2. Sanchez, T., and T. Hla. 2004. Structural and functional characteristics of S1P receptors. J. Cell. Biochem. 92 : 913-922.
3. Pappu, R., S. R. Schwab, I. Cornelissen, J. P. Pereira, J. B. Regard, Y. Xu, E. Camerer, Y. W. Zheng, Y. Huang, J. G. Cyster, et al. 2007. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science. 316 : 295-298.
4. Rivera, J., R. L. Proia, and A. Olivera. 2008. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 8 : 753-763.
5. Thangada, S., K. M. Khanna, V. A. Blaho, M. L. Oo, D. S. Im, C. Guo, L. Lefrancois, and T. Hla. 2010. Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics. J. Exp. Med. 207 : 1475-1483.
6. McVerry, B. J., and J. G. Garcia. 2005. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell. Signal. 17 : 131-139.
7. Wang, L., and S. M. Dudek. 2009. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc. Res. 77 : 39-45.
8. Alewijnse, A. E., S. L. Peters, and M. C. Michel. 2004. Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. Br. J. Pharmacol. 143 : 666-684.
9. Chae, S. S., R. L. Proia, and T. Hla. 2004. Constitutive expression of the S1P1 receptor in adult tissues. Prostaglandins Other Lipid Mediat. 73 : 141-150.
10. Hla, T., and T. Maciag. 1990. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 265 : 9308-9313.
11. Allende, M. L., T. Yamashita, and R. L. Proia. 2003. G-proteincoupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood. 102 : 3665-3667.
12. Kono, M., Y. Mi, Y. Liu, T. Sasaki, M. L. Allende, Y. P. Wu, T. Yamashita, and R. L. Proia. 2004. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J. Biol. Chem. 279 : 29367-29373.
13. Liu, Y., R. Wada, T. Yamashita, Y. Mi, C. X. Deng, J. P. Hobson, H. M. Rosenfeldt, V. E. Nava, S. S. Chae, M. J. Lee, et al. 2000. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106 : 951-961.
14. Gaengel, K., C. Niaudet, K. Hagikura, B. L. Siemsen, L. Muhl, J. J. Hofmann, L. Ebarasi, S. Nystrom, S. Rymo, L. L. Chen, et al. 2012. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev. Cell. 23 : 587-599.
15. Jung, B., H. Obinata, S. Galvani, K. Mendelson, B. S. Ding, A. Skoura, B. Kinzel, V. Brinkmann, S. Rafi i, T. Evans, et al. 2012. Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. Dev. Cell. 23 : 600-610.
16. Brinkmann, V., M. D. Davis, C. E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, et al. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277 : 21453-21457.
17. Mandala, S., R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G. J. Shei, D. Card, C. Keohane, et al. 2002. Alteration of lymphocyte traffi cking by sphingosine-1-phosphate receptor agonists. Science. 296 : 346-349.
18. Billich, A., F. Bornancin, P. Devay, D. Mechtcheriakova, N. Urtz, and T. Baumruker. 2003. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 278 : 47408-47415.
19. Gräler, M. H., and E. J. Goetzl. 2004. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18 : 551-553.
20. Sanchez, T., T. Estrada-Hernandez, J. H. Paik, M. T. Wu, K. Venkataraman, V. Brinkmann, K. Claffey, and T. Hla. 2003. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem. 278 : 47281-47290.
21. Matloubian, M., C. G. Lo, G. Cinamon, M. J. Lesneski, Y. Xu, V. Brinkmann, M. L. Allende, R. L. Proia, and J. G. Cyster. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 427 : 355-360.
22. Brinkmann, V., A. Billich, T. Baumruker, P. Heining, R. Schmouder, G. Francis, S. Aradhye, and P. Burtin. 2010. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 9 : 883-897.
23. Chun, J., and H. P. Hartung. 2010. Mechanism of action of oral fi ngolimod (FTY720) in multiple sclerosis. Clin. Neuropharmacol. 33 : 91-101.
24. Cohen, J. A., F. Barkhof, G. Comi, H. P. Hartung, B. O. Khatri, X. Montalban, J. Pelletier, R. Capra, P. Gallo, G. Izquierdo, et al. 2010. Oral fi ngolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 362 : 402-415.
25. Pan, S., Y. Mi, C. Pally, C. Beerli, A. Chen, D. Guerini, K. Hinterding, B. Nuesslein-Hildesheim, T. Tuntland, S. Lefebvre, et al. 2006. A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem. Biol. 13 : 1227-1234.
26. Oo, M. L., S. H. Chang, S. Thangada, M. T. Wu, K. Rezaul, V. Blaho, S. I. Hwang, D. K. Han, and T. Hla. 2011. Engagementof S1P(1)-degradative mechanisms leads to vascular leak in mice. J. Clin. Invest. 121 : 2290-2300.
27. Monteleone, G., F. Pallone, and T. T. MacDonald. 2011. Emerging immunological targets in infl ammatory bowel disease. Curr. Opin. Pharmacol. 11 : 640-645.
28. Chidlow, J. H., Jr., W. Langston, J. J. Greer, D. Ostanin, M. Abdelbaqi, J. Houghton, A. Senthilkumar, D. Shukla, A. P. Mazar, M. B. Grisham, et al. 2006. Differential angiogenic regulation of experimental colitis. Am. J. Pathol. 169 : 2014-2030.
29. Chidlow, J. H., Jr., D. Shukla, M. B. Grisham, and C. G. Kevil. 2007. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. Am. J. Physiol. Gastrointest. Liver Physiol. 293 : G5-G18.
30. Otani, T., K. Yamaguchi, E. Scherl, B. Du, H. H. Tai, M. Greifer, L. Petrovic, T. Daikoku, S. K. Dey, K. Subbaramaiah, et al. 2006. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in infl ammatory bowel disease: evidence for involvement of TNF-alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 290 : G361-G368.
31. Zhang, L., M. Orban, M. Lorenz, V. Barocke, D. Braun, N. Urtz, C. Schulz, M. L. von Bruhl, A. Tirniceriu, F. Gaertner, et al. 2012. A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. J. Exp. Med. 209 : 2165-2181.
32. Lee, M. J., S. Thangada, K. P. Claffey, N. Ancellin, C. H. Liu, M. Kluk, M. Volpi, R. I. Sha'afi, and T. Hla. 1999. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 99 : 301-312.
33. Carmeliet, P., M. G. Lampugnani, L. Moons, F. Breviario, V. Compernolle, F. Bono, G. Balconi, R. Spagnuolo, B. Oosthuyse, M. Dewerchin, et al. 1999. Targeted defi ciency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 98 : 147-157.
34. Kappos, L., E. W. Radue, P. O'Connor, C. Polman, R. Hohlfeld, P. Calabresi, K. Selmaj, C. Agoropoulou, M. Leyk, L. Zhang-Auberson, et al. 2010. A placebo-controlled trial of oral fi ngolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362 : 387-401.
35. Daniel, C., N. Sartory, N. Zahn, G. Geisslinger, H. H. Radeke, and J. M. Stein. 2007. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells. J. Immunol. 178 : 2458-2468.
36. Daniel, C., N. A. Sartory, N. Zahn, R. Schmidt, G. Geisslinger, H. H. Radeke, and J. M. Stein. 2007. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions. Mol. Immunol. 44 : 3305-3316.
37. Montrose, D. C., N. A. Horelik, J. P. Madigan, G. D. Stoner, L. S. Wang, R. S. Bruno, H. J. Park, C. Giardina, and D. W. Rosenberg. 2011. Anti-infl ammatory effects of freeze-dried black raspberry powder in ulcerative colitis. Carcinogenesis. 32 : 343-350.
38. Yan, Y., V. Kolachala, G. Dalmasso, H. Nguyen, H. Laroui, S. V. Sitaraman, and D. Merlin. 2009. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS ONE. 4 : e6073.
39. Snider, A. J., T. Kawamori, S. G. Bradshaw, K. A. Orr, G. S. Gilkeson, Y. A. Hannun, and L. M. Obeid. 2009. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J. 23 : 143-152.
40. Kohno, M., M. Momoi, M. L. Oo, J. H. Paik, Y. M. Lee, K. Venkataraman, Y. Ai, A. P. Ristimaki, H. Fyrst, H. Sano, et al. 2006. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell. Biol. 26 : 7211-7223.
41. Schulze, T., S. Golfi er, C. Tabeling, K. Rabel, M. H. Graler, M. Witzenrath, and M. Lipp. 2011. Sphingosine-1-phospate receptor 4 (S1P(4)) defi ciency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. FASEB J. 25 : 4024-4036.